What is the average price target for IBOTTA INC-CL A (IBTA) stock?
14 analysts have analysed IBTA and the average price target is 28.56 USD. This implies a price increase of 4.16% is expected in the next year compared to the current price of 27.42.
NYSE:IBTA • US4510511060
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IBOTTA INC-CL A (IBTA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-26 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-13 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-11-13 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-11-13 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-10-15 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2025-08-14 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-08-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-14 | Needham | Maintains | Buy -> Buy |
| 2025-08-14 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-08-14 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-08-14 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2025-08-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-05-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-15 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-15 | Needham | Maintains | Buy -> Buy |
| 2025-05-15 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-04-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-10 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-02-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-02-27 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-01-27 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 320.037M 51.89% | 367.254M 14.75% | 342.389M -6.77% | 349.29M 2.02% | 380.57M 8.96% | 427.99M 12.46% | |
| EBITDA YoY % growth | 62.624M 284.22% | 36.005M -42.51% | 10.179M -71.73% | 43.472M 327.08% | 56.221M 29.33% | 81.373M 44.74% | |
| EBIT YoY % growth | 55.96M 238.81% | 27.925M -50.10% | 1.859M -93.34% | -25.547M -1,474.24% | -12.408M 51.43% | 4.944M 139.85% | |
| Operating Margin | 17.49% | 7.60% | 0.54% | -7.31% | -3.26% | 1.16% | |
| EPS YoY % growth | N/A | 0.19 | 0.15 -21.05% | -0.60 -497.32% | -0.50 16.14% | 0.11 122.45% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -610.00% | -0.24 -399.63% | -0.04 -185.68% | -0.03 36.25% | -0.34 -10.00% | -0.07 70.21% | 0.06 242.86% | 0.02 180.00% |
| Revenue Q2Q % growth | 81.663M -3.44% | 84.913M -1.30% | 84.388M 1.35% | 90.525M 2.26% | 81.641M -0.03% | 86.374M 1.72% | 91.239M 8.12% | 95.717M 5.74% |
| EBITDA Q2Q % growth | 7.327M 661.64% | 10.019M 55.38% | 13.456M 56.12% | 12.113M 76.11% | 5.518M -24.69% | 12.475M 24.51% | 16.269M 20.91% | 12.76M 5.34% |
| EBIT Q2Q % growth | -9.768M -711.99% | -4.804M -361.37% | 1.545M -44.14% | -418.2K 71.00% | 3.407M 134.88% | 10.343M 315.30% | 14.096M 812.36% | 10.557M 2,624.39% |
All data in USD
14 analysts have analysed IBTA and the average price target is 28.56 USD. This implies a price increase of 4.16% is expected in the next year compared to the current price of 27.42.
IBOTTA INC-CL A (IBTA) will report earnings on 2026-05-18.
The consensus EPS estimate for the next earnings of IBOTTA INC-CL A (IBTA) is -0.31 USD and the consensus revenue estimate is 81.66M USD.
The number of analysts covering IBOTTA INC-CL A (IBTA) is 14.